Abiopharma

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019963 Size: 5 KB

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 4 - Pacira BioSciences, Inc. Filed: 2025-08-04 AccNo: 0001396814-25-000095 Size: 5 KB

New Form SCHEDULE 13G - ImageneBio, Inc. Filed: 2025-08-04 AccNo: 0001172661-25-002868 Size: 11 KB

New Form 4 - Cencora, Inc. Filed: 2025-08-04 AccNo: 0001986505-25-000005 Size: 4 KB

New Form SCHEDULE 13G/A - ClearPoint Neuro, Inc. Filed: 2025-08-04 AccNo: 0000921895-25-002077 Size: 20 KB

New Form 6-K - Cellectis S.A. Filed: 2025-08-04 AccNo: 0000950170-25-102055 Size: 3 MB

New Form SCHEDULE 13G/A - ImageneBio, Inc. Filed: 2025-08-04 AccNo: 0001172661-25-002867 Size: 11 KB

New Form 4 - Phreesia, Inc. Filed: 2025-08-04 AccNo: 0001127602-25-019958 Size: 5 KB

HealthStream Announces Second Quarter 2025 Results

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

Pablo Perversi to Join METTLER TOLEDO Board of Directors

Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET

New Form 4 - Simulations Plus, Inc. Filed: 2025-08-04 AccNo: 0001628280-25-037453 Size: 6 KB